Real World Talk with COTA brings together healthcare leaders to discuss the importance of real world data in accelerating drug development and improving cancer care. Real World Talk is brought to you by COTA, a company that combines oncology expertise with advanced technology & analytics to create clarity from fragmented and often-inaccessible real-world data.
All content for Real World Talk with COTA is the property of COTA and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Real World Talk with COTA brings together healthcare leaders to discuss the importance of real world data in accelerating drug development and improving cancer care. Real World Talk is brought to you by COTA, a company that combines oncology expertise with advanced technology & analytics to create clarity from fragmented and often-inaccessible real-world data.
Real World Data Keeps the Research Cycle Moving With Jeff Allen
Real World Talk with COTA
23 minutes 53 seconds
4 years ago
Real World Data Keeps the Research Cycle Moving With Jeff Allen
In the period of crisis, what really makes a difference and gives hope is unity and partnership. The outbreak of coronavirus has shown us how valuable shared efforts are. The last year taught us many things and challenged us. However, it remains to be seen whether the healthcare system and we, as a community, will adopt these lessons in the future.
In this episode of the Real World Talk podcast, Andrew Belli welcomes Jeff Allen, the president and CEO of Friends of Cancer Research. Jeff talks about his organization and its work during the pandemic. He also talks about real-world data pilot projects and says the partnership was the main component of their success.
Real World Talk with COTA
Real World Talk with COTA brings together healthcare leaders to discuss the importance of real world data in accelerating drug development and improving cancer care. Real World Talk is brought to you by COTA, a company that combines oncology expertise with advanced technology & analytics to create clarity from fragmented and often-inaccessible real-world data.